{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T18:33:15Z","timestamp":1788201195035,"version":"build-2803163510"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,3,15]],"date-time":"2018-03-15T00:00:00Z","timestamp":1521072000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"AstraZeneca, Inc., Wilmington, Delaware"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12882-018-0861-1","type":"journal-article","created":{"date-parts":[[2018,3,15]],"date-time":"2018-03-15T09:46:23Z","timestamp":1521107183000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":62,"title":["Prevalence, treatment patterns, and healthcare resource utilization in Medicare and commercially insured non-dialysis-dependent chronic kidney disease patients with and without anemia in the United States"],"prefix":"10.1186","volume":"19","author":[{"given":"Wendy L.","family":"St. Peter","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haifeng","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaum","family":"Kabadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David T.","family":"Gilbertson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trudy","family":"Pendergraft","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suying","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,3,15]]},"reference":[{"key":"861_CR1","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1001\/archinte.162.12.1401","volume":"162","author":"BC Astor","year":"2002","unstructured":"Astor BC, Muntner P, Levin A, Eustace JA, Coresh J. Association of kidney function with anemia: the third National Health and nutrition examination survey (1988-1994). Arch Intern Med. 2002;162:1401\u20138.","journal-title":"Arch Intern Med"},{"key":"861_CR2","doi-asserted-by":"publisher","first-page":"e84943","DOI":"10.1371\/journal.pone.0084943","volume":"9","author":"ME Stauffer","year":"2014","unstructured":"Stauffer ME, Fan T. Prevalence of anemia in chronic kidney disease in the United States. PLoS One. 2014;9:e84943.","journal-title":"PLoS One"},{"key":"861_CR3","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1053\/j.ajkd.2014.05.013","volume":"64","author":"M Thamer","year":"2014","unstructured":"Thamer M, Zhang Y, Kshirsagar O, Cotter DJ, Kaufman JS. Erythropoiesis-stimulating agent use among non-dialysis-dependent CKD patients before and after the trial to reduce cardiovascular events with Aranesp therapy (TREAT) using a large US health plan database. Am J Kidney Dis. 2014;64:706\u201313.","journal-title":"Am J Kidney Dis"},{"key":"861_CR4","doi-asserted-by":"publisher","first-page":"2019","DOI":"10.1056\/NEJMoa0907845","volume":"361","author":"MA Pfeffer","year":"2009","unstructured":"Pfeffer MA, Burdmann EA, Chen CY, Cooper ME, de Zeeuw D, Eckardt KU, et al. A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease. N Engl J Med. 2009;361:2019\u201332.","journal-title":"N Engl J Med"},{"key":"861_CR5","doi-asserted-by":"publisher","first-page":"2071","DOI":"10.1056\/NEJMoa062276","volume":"355","author":"TB Drueke","year":"2006","unstructured":"Drueke TB, Locatelli F, Clyne N, Eckardt KU, Macdougall IC, Tsakiris D, et al. Normalization of hemoglobin level in patients with chronic kidney disease and anemia. N Engl J Med. 2006;355:2071\u201384.","journal-title":"N Engl J Med"},{"key":"861_CR6","doi-asserted-by":"publisher","first-page":"2085","DOI":"10.1056\/NEJMoa065485","volume":"355","author":"AK Singh","year":"2006","unstructured":"Singh AK, Szczech L, Tang KL, Barnhart H, Sapp S, Wolfson M, et al. Correction of anemia with epoetin alfa in chronic kidney disease. N Engl J Med. 2006;355:2085\u201398.","journal-title":"N Engl J Med"},{"key":"861_CR7","unstructured":"U.S. Food and Drug Administration. FDA drug safety communication: modified dosing recommendations to improve the safe use of erythropoiesis-stimulating agents (ESAs) in chronic kidney disease. 2011. \n                    http:\/\/www.fda.gov\/Drugs\/DrugSafety\/ucm259639.htm\n                    \n                  . Accessed 19 Jan 2018."},{"key":"861_CR8","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1038\/kisup.2012.37","volume":"2","author":"Kidney Disease","year":"2012","unstructured":"Kidney Disease. Improving global outcomes (KDIGO) anemia work group. KDIGO clinical practice guideline for anemia in chronic kidney disease. Kidney Int Suppl (2011). 2012;2:279\u2013335.","journal-title":"Kidney Int Suppl (2011)"},{"key":"861_CR9","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1046\/j.1523-1755.2002.00432.x","volume":"62","author":"SS Khan","year":"2002","unstructured":"Khan SS, Kazmi WH, Abichandani R, Tighiouart H, Pereira BJ, Kausz AT. Health care utilization among patients with chronic kidney disease. Kidney Int. 2002;62:229\u201336.","journal-title":"Kidney Int"},{"key":"861_CR10","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000000964","volume":"94","author":"K Garlo","year":"2015","unstructured":"Garlo K, Williams D, Lucas L, Wong R, Botler J, Abramson S, et al. Severity of anemia predicts hospital length of stay but not readmission in patients with chronic kidney disease: a retrospective cohort study. Medicine (Baltimore). 2015;94:e964.","journal-title":"Medicine (Baltimore)"},{"key":"861_CR11","unstructured":"Truven Health. MarketScan\u00ae research. 2016. \n                    https:\/\/marketscan.truvenhealth.com\/marketscanportal\/portal.aspx\n                    \n                  . Accessed 19 Jan 2018."},{"key":"861_CR12","doi-asserted-by":"publisher","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","volume":"150","author":"AS Levey","year":"2009","unstructured":"Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF III, Feldman HI, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150:604\u201312.","journal-title":"Ann Intern Med"},{"key":"861_CR13","doi-asserted-by":"publisher","first-page":"e0166635","DOI":"10.1371\/journal.pone.0166635","volume":"11","author":"CH Le","year":"2016","unstructured":"Le CH. The prevalence of anemia and moderate-severe anemia in the US population (NHANES 2003-2012). PLoS One. 2016;11:e0166635.","journal-title":"PLoS One"},{"key":"861_CR14","doi-asserted-by":"publisher","first-page":"2237","DOI":"10.1093\/ndt\/gfp758","volume":"25","author":"EV Lawler","year":"2010","unstructured":"Lawler EV, Gagnon DR, Fink J, Seliger S, Fonda J, Do TP, et al. Initiation of anaemia management in patients with chronic kidney disease not on dialysis in the veterans health administration. Nephrol Dial Transplant. 2010;25:2237\u201344.","journal-title":"Nephrol Dial Transplant"},{"key":"861_CR15","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/1471-2369-13-5","volume":"13","author":"KM Fox","year":"2012","unstructured":"Fox KM, Yee J, Cong Z, Brooks JM, Petersen J, Lamerato L, et al. Transfusion burden in non-dialysis chronic kidney disease patients with persistent anemia treated in routine clinical practice: a retrospective observational study. BMC Nephrol. 2012;13:5.","journal-title":"BMC Nephrol"},{"key":"861_CR16","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1001\/jamainternmed.2014.87","volume":"174","author":"WC Winkelmayer","year":"2014","unstructured":"Winkelmayer WC, Mitani AA, Goldstein BA, Brookhart MA, Chertow GM. Trends in anemia care in older patients approaching end-stage renal disease in the United States (1995-2010). JAMA Intern Med. 2014;174:699\u2013707.","journal-title":"JAMA Intern Med"},{"key":"861_CR17","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1097\/01.tp.0000437435.19980.8f","volume":"97","author":"MS Leffell","year":"2014","unstructured":"Leffell MS, Kim D, Vega RM, Zachary AA, Petersen J, Hart JM, et al. Red blood cell transfusions and the risk of allosensitization in patients awaiting primary kidney transplantation. Transplantation. 2014;97:525\u201333.","journal-title":"Transplantation"},{"key":"861_CR18","doi-asserted-by":"publisher","first-page":"2908","DOI":"10.1093\/ndt\/gft362","volume":"28","author":"JM Yabu","year":"2013","unstructured":"Yabu JM, Anderson MW, Kim D, Bradbury BD, Lou CD, Petersen J, et al. Sensitization from transfusion in patients awaiting primary kidney transplant. Nephrol Dial Transplant. 2013;28:2908\u201318.","journal-title":"Nephrol Dial Transplant"},{"key":"861_CR19","volume-title":"National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 2010","author":"U.S. Renal Data System","year":"2010","unstructured":"U.S. Renal Data System. USRDS 2010 Annual data report: atlas of Chronic Kidney Disease & end-Stage Renal Disease in the United States. In: Bethesda MD, editor. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 2010; 2010."},{"key":"861_CR20","doi-asserted-by":"publisher","first-page":"e001480","DOI":"10.1161\/JAHA.114.001480","volume":"4","author":"SC Hung","year":"2015","unstructured":"Hung SC, Kuo KL, Peng CH, Wu CH, Wang YC, Tarng DC. Association of fluid retention with anemia and clinical outcomes among patients with chronic kidney disease. J Am Heart Assoc. 2015;4:e001480.","journal-title":"J Am Heart Assoc"},{"key":"861_CR21","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1111\/j.1532-5415.2012.03941.x","volume":"60","author":"EF Binder","year":"2012","unstructured":"Binder EF, White HK, Resnick B, McClellan WM, Lei L, Ouslander JG. A prospective study of outcomes of nursing home residents with chronic kidney disease with and without anemia. J Am Geriatr Soc. 2012;60:877\u201383.","journal-title":"J Am Geriatr Soc"},{"key":"861_CR22","doi-asserted-by":"publisher","first-page":"1818","DOI":"10.1001\/jamainternmed.2016.6520","volume":"176","author":"C Wang","year":"2016","unstructured":"Wang C, Kane R, Levenson M, Kelman J, Wernecke M, Lee JY, et al. Association between changes in CMS reimbursement policy and drug labels for erythrocyte-stimulating agents with outcomes for older patients undergoing hemodialysis covered by fee-for-service Medicare. JAMA Intern Med. 2016;176:1818\u201325.","journal-title":"JAMA Intern Med"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-018-0861-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12882-018-0861-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-018-0861-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,3,14]],"date-time":"2019-03-14T20:23:20Z","timestamp":1552595000000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/s12882-018-0861-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,15]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["861"],"URL":"https:\/\/doi.org\/10.1186\/s12882-018-0861-1","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3,15]]},"assertion":[{"value":"19 September 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 March 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 March 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"We applied to and received approval from the Human Subjects Research Committee of the Hennepin County Medical Center\/Hennepin Healthcare System, Inc. We used retrospective data from the Truven Health MarketScan database and CMS Medicare data under data use agreements and obtained a waiver of consent as obtaining consent would have been an unreasonable burden.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Drs. St. Peter, Gilbertson, and Li, Ms. Guo, and Mr. Peng report no competing financial interests. Dr. Kabadi and Ms. Pendergraft are employed by AstraZeneca. The results presented in this paper have not been published previously in whole or part, except in abstract format.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"67"}}